Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer.

ABSTRACT: We conducted a genome-wide SNP association study on prostate cancer on over 23,000 Icelanders, followed by a replication study including over 15,500 individuals from Europe and the United States. Two newly identified variants were shown to be associated with prostate cancer: rs5945572 on Xp11.22 and rs721048 on 2p15 (odds ratios (OR) = 1.23 and 1.15; P = 3.9 x 10(-13) and 7.7 x 10(-9), respectively). The 2p15 variant shows a significantly stronger association with more aggressive, rather than less aggressive, forms of the disease.

SUBMITTER: Gudmundsson J 

PROVIDER: S-EPMC3598012 | biostudies-literature | 2008 Mar

REPOSITORIES: biostudies-literature